Free News Feed
Get our RSS Feed!
© Copyright 2026 StreetInsider.com
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
WIXOM, Mich., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, reported results for the third quarter of 2015.
Q3 2015 Financial Highlights
Sales were $14.4 million, $0.6 million or 4.6% higher than the third quarter of 2014. Gross profit was $2.5 million, a 10.3% increase over Q3 2014. Gross profit margins increased to 17.4% compared to 16.5% in Q3 2014. SG&A expense was $3.8 million, a decrease of... More